Consumer Product Recalls

Hazard: A detached fuel line can leak, increasing the risk of a fire.

Hazard: A closing window that does not reverse direction as expected can pinch a passenger before retracting, increasing the risk of injury.

Hazard: In an emergency, first responders may not receive notification of the crash or emergency location, increasing the risk of injury to riders.

Hazard: A rearview image that does not display reduces the driver's view of what is behind the vehicle and increases the risk of a crash.

Hazard: An improperly secured battery may become damaged in a crash, increasing the risk of a fire.

Hazard: The magnets on the inside cover can detach, posing an ingestion hazard to children. When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting and/or blockage of the intestines, infection, blood poisoning and death.

Hazard: The battery compartment of the recalled light-up ruler bracelets can be opened easily by children allowing access to the button cell batteries, violating the battery-operated toys requirements under the mandatory standard for toys. If a child swallows a button cell or coin battery, it can cause serious injuries, internal chemical burns or death.

Hazard: The battery compartment of the recalled light-up ruler bracelets can be opened easily by children, allowing access to the button cell batteries, violating the battery-operated toys requirements under the mandatory standard for toys. If a child swallows a button cell or coin battery, it can cause serious injuries, internal chemical burns or death.

Hazard: The e-bikes' lithium-ion battery can overheat and ignite, posing serious fire and burn hazards to consumers.

Hazard: The weld line on the electric scooter can crack, causing the stem to break and posing fall and injury hazards.

Hazard: The recalled gates violate the mandatory standard for expansion gates and expandable enclosures because a child's torso can fit through the opening between the gate and the floor, posing a risk of serious injury or death due to entrapment.

Hazard: The recalled dressers are unstable if they are not anchored to the wall, posing serious tip-over and entrapment hazards that can result in injuries or death to children. The dressers fail to meet the mandatory standard, as required by the STURDY Act.

Hazard: The recalled bottles contain turpentine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The turpentine bottles violate the mandatory standard for child-resistant packaging, posing a deadly poisoning hazard to young children.

Hazard: The recalled LED gloves violate the mandatory standard for toys containing coin batteries because the compartment that holds the batteries can be easily accessed and opened by children. Additionally, the spare coin batteries provided with the toys are not in child-resistant packaging and do not have the warnings required under Reese's Law. When button cell or coin batteries are swallowed, the ingested batteries can cause serious injuries, internal chemical burns and death.

Hazard: The bottles contain turpentine, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are ingested by young children.

Hazard: The rechargeable battery in the Electric Bug Zapper Racket, Fly Swatter, and Mosquito Swatter can catch fire when used for extended periods of time.

Hazard: The minifridges' internal electrical components can short circuit and ignite the surrounding plastic housing, posing fire and burn hazards.

Hazard: The recalled hoses can burst, posing an impact hazard and a risk of temporarily impaired hearing.

Hazard: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no reset has actually occurred and there are no parameter changes or loss of diagnostics. Prior to this software update, if an erroneous SmartSync message was displayed, confusion regarding the message could have caused a clinician to consider an unnecessary system revision. Medtronic has received 39 reports of this display error with two instances of unnecessary device explant through 30 April 2025.

Hazard: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no reset has actually occurred and there are no parameter changes or loss of diagnostics. Prior to this software update, if an erroneous SmartSync message was displayed, confusion regarding the message could have caused a clinician to consider an unnecessary system revision. Medtronic has received 39 reports of this display error with two instances of unnecessary device explant through 30 April 2025.

Hazard: Due to packaging discrepancy with the incorrect tibial inserts/implants being packaged. The use of this product may result in the incorrect product being selected. This could result in a revision surgery if used.

Hazard: Due to packaging discrepancy with the incorrect tibial inserts/implants being packaged. The use of this product may result in the incorrect product being selected. This could result in a revision surgery if used.

Hazard: Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.

Hazard: Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7 days after reconstitution; however, the label stability claims for the PV fluids is 7 days following reconstitution. This may lead to inaccurate QC results. The use of the PVs when the QC results are outside of the customer s established ranges could result in delayed results for patients due to the need to repeat QC testing or reconstitute new PV fluids and repeat testing. It could also result in erroneous patient results (small positive bias).

Hazard: Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7 days after reconstitution; however, the label stability claims for the PV fluids is 7 days following reconstitution. This may lead to inaccurate QC results. The use of the PVs when the QC results are outside of the customer s established ranges could result in delayed results for patients due to the need to repeat QC testing or reconstitute new PV fluids and repeat testing. It could also result in erroneous patient results (small positive bias).

Hazard: Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7 days after reconstitution; however, the label stability claims for the PV fluids is 7 days following reconstitution. This may lead to inaccurate QC results. The use of the PVs when the QC results are outside of the customer s established ranges could result in delayed results for patients due to the need to repeat QC testing or reconstitute new PV fluids and repeat testing. It could also result in erroneous patient results (small positive bias).

Hazard: Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7 days after reconstitution; however, the label stability claims for the PV fluids is 7 days following reconstitution. This may lead to inaccurate QC results. The use of the PVs when the QC results are outside of the customer s established ranges could result in delayed results for patients due to the need to repeat QC testing or reconstitute new PV fluids and repeat testing. It could also result in erroneous patient results (small positive bias).

Hazard: Due to manufacturing error, Intraosseous device built-in stabilizer may not be released properly after deployment and insertion.

Hazard: Due to manufacturing error, Intraosseous device built-in stabilizer may not be released properly after deployment and insertion.

Hazard: Due to a manufacturing issue, disinfecting cap for needle-free connectors may have an incomplete seal between the foil lid and plastic container, which may result in isopropyl alcohol evaporation from the sponge, which may result in inadequate disinfection.